How to handle opioid constipation. Bath emollients are a washout for childhood eczema. Does warfarin cause acute kidney injury? And there may be a new option for postpartum depression.

Fewer smokes mean fewer strokes. Are biopsy’s days numbered for diagnosing celiac disease? The perils of endoscopic therapy for Barrett’s esophagus. And is your EHR preventing breastfeeding?

Is "medical aid in dying" suicide? PPIs remain suspects in cognitive decline. Which beta-blocker is best for hypertension? And one in five Medicaid kids may have a mental health diagnosis.

Long-acting contraceptive uptake surged immediately after Trump’s election. Universal BRCA testing is worthwhile for relatives of high-grade serous ovarian cancer patients. Patient-reported outcomes show impairment decades after acute knee injury. And CMS floats the idea of Medicare direct provider contracting.

Female physicians face an enduring wage gap. A metabolic syndrome scoring system predicts cardiovascular disease risk in type 2 diabetes. A national suicide hotline could become a reality. And anticholinergics’ link to dementia calls for vigilance in elderly patients.

How smartphones could battle oral cancer. An old Medicare foe has a new name. What twins tell us about acne risk. And what FDA panel speakers may be hiding.

Lupus is quietly killing young women. Is celecoxib's cardiovascular danger overrated? Which sleep disorders pose the greatest driving risk. And does substance abuse trigger schizophrenia?

Which nonopioid prescription drugs are ripe for abuse? There’s new clarity on multiple sclerosis therapy. How infections boost Sjogren's syndrome risk. And bum kidneys shouldn’t stop dabigatran reversal.

Physician burnout needs more than yoga. A new oral agent targets migraine pain. Is metabolically healthy obesity actually healthy? And triple-agent therapy cuts COPD exacerbations.

How physicians are addressing gender equality, a statin rechallenge plan, social determinants of health, and the cost of surgeries.